-
Mashup Score: 0Firstborn Twins May Have Higher Risk of Leukemia - 8 hour(s) ago
New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Cancer Incidence on the Rise Among Women - 2 day(s) ago
In women, the cancer incidence increased 23% during 1978-2021.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Though the rate of #cancerdeath is declining in the United States, #cancerIncidence is rising among US women, according to a report from the @AmericanCancer published in @CACancerJournal. https://t.co/8cYt9QbLtO
-
-
Mashup Score: 0
The combination of talquetamab and teclistamab “warrants further investigation in patients with relapsed or refractory multiple myeloma,” according to researchers.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of talquetamab and teclistamab demonstrated activity in patients with R/R #multipleMyeloma in a phase 1/2 trial. Published in @NEJM. https://t.co/sxKxXCDNJM #mmsm
-
-
Mashup Score: 0
Zenocutuzumab produced responses in patients with lung, pancreatic, breast, gastric, and ovarian cancers as well as cholangiocarcinoma.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Zenocutuzumab — a bispecific antibody targeting HER2 and HER3 — demonstrated efficacy in patients with advanced NRG1 fusion-positive cancer, particularly those with non-small-cell lung cancer and #pancreaticCancer. https://t.co/8NaYt3vZI1 #NSCLC #pancsm
-
-
Mashup Score: 0Can PORTOS Guide Radiotherapy Dosing in Prostate Cancer? - 10 day(s) ago
PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
PORTOS can determine which prostate cancer patients will benefit from RT dose-escalation, according to Dr Shuang (George) Zhao from @UWMadison. He presented the findings at #ASCOGU25. #GU25 #gucsm #pcsm https://t.co/LXLWowdtYY https://t.co/jPYIbWCRjB
-
-
Mashup Score: 0Talazoparib Improves OS as First-Line Treatment in mCRPC - 10 day(s) ago
Adding talazoparib to first-line treatment with enzalutamide can improve overall survival in patients with mCRPC, phase 3 data suggest.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Updated results from TALAPRO-2 support talazoparib + enzalutamide as a standard initial treatment option for mCRPC, @neerajaiims from @huntsmancancer said at #ASCOGU25. #GU25 #gucsm #pcsm https://t.co/2Rq97QgErk
-
-
Mashup Score: 1Higher Maternal BMI During Pregnancy May Increase the Risk of ALL in Female Offspring - 11 day(s) ago
Researchers found that higher maternal BMI in early pregnancy and before delivery were associated with an increased risk of ALL in female offspring, but there were no such associations for male offspring.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Maternal BMI during pregnancy may be associated with the risk of childhood acute #lymphoblasticLeukemia in female offspring. Published in @LeukemiaJnl. https://t.co/6YtnNT4kjx #leusm
-
-
Mashup Score: 0Excess BMI May Increase Risk of Progression From MGUS to MM - 11 day(s) ago
Being obese at the time of MGUS diagnosis was associated with a 27% increase in the risk of progression to MM.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Having a BMI in the normal range at diagnosis and maintaining a normal BMI over time may prevent progression from MGUS to #multipleMyeloma. Published in @JAMANetworkOpen. https://t.co/wuEE5JhuuG
-
-
Mashup Score: 0
The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The #Trump administration’s #censorship has extended beyond federal websites and datasets to include research published in academic journals. Featuring statements from @ACSCAN, @AmerAcadPeds, and others. https://t.co/HdGP5Le1Fw
-
-
Mashup Score: 0
The NIH said capping indirect cost payments will save billions of dollars. Universities said it will disrupt vital, life-saving research.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The NIH has capped indirect cost payments on research grants at 15%, but a temporary restraining order has put this action on hold in 22 states. https://t.co/fOLl4tWoW9
-
Firstborn twins may have a greater risk of developing #leukemia than second-born twins. Published in @Haematologica. https://t.co/gq2X4ecS2J #leusm